On the other hand, EGFR kinase domain activating point mutations are associated with non-small cell lung carcinoma and glioblastoma, but are rarely seen in other types of cancer (Li et al., 2008; Siegelin and Borczuk, 2014; Zhang et al., 2016). This evidence concerns the gene EGFR and glioblastoma.